1. Academic Validation
  2. Orellanine: From Fungal Origin to a Potential Future Cancer Treatment

Orellanine: From Fungal Origin to a Potential Future Cancer Treatment

  • J Nat Prod. 2023 Jun 23;86(6):1620-1631. doi: 10.1021/acs.jnatprod.2c01068.
Mark J Lyons 1 Carsten Ehrhardt 1 John J Walsh 1
Affiliations

Affiliation

  • 1 School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin 2, Ireland.
Abstract

Fungal metabolites represent an underutilized resource in the development of novel Anticancer drugs. This review will focus on the promising Fungal nephrotoxin orellanine, found in mushrooms including Cortinarius orellanus (Fools webcap). Emphasis will be placed on its historical significance, structural features, and associated toxicomechanics. Chromatographic methods for analysis of the compound and its metabolites, its synthesis, and chemotherapeutic potential are also discussed. Although orellanine's exceptional selectivity for proximal tubular cells is well documented, the mechanics of its toxicity in kidney tissue remains disputed. Here, the most commonly proposed hypotheses are detailed in the context of the molecule's structure, the symptoms seen following ingestion, and its characteristic prolonged latency period. Chromatographic analysis of orellanine and its related substances remains challenging, while biological evaluation of the compound is complicated by uncertainty regarding the role of active metabolites. This has limited efforts to structurally refine the molecule; despite numerous established methods for its synthesis, there is minimal published material on how orellanine's structure might be optimized for therapeutic use. Despite these obstacles, orellanine has generated promising data in preclinical studies of metastatic clear cell renal cell carcinoma, leading to the early 2022 announcement of phase I/II trials in humans.

Figures
Products